These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 10030315)
41. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Nagata H; Worobec AS; Oh CK; Chowdhury BA; Tannenbaum S; Suzuki Y; Metcalfe DD Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10560-4. PubMed ID: 7479840 [TBL] [Abstract][Full Text] [Related]
42. Clinical varieties of mastocytoses. Puretić S; Milavec D Acta Med Croatica; 2001; 55(2):61-6. PubMed ID: 11505629 [TBL] [Abstract][Full Text] [Related]
43. [Mastocytosis--a review illustrated by two case reports]. Dalgaard J; Ritland S; Brinch L; Ikonomou IM Tidsskr Nor Laegeforen; 2000 Apr; 120(11):1312-5. PubMed ID: 10868093 [TBL] [Abstract][Full Text] [Related]
44. Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice. Ustun C; Arock M; Kluin-Nelemans HC; Reiter A; Sperr WR; George T; Horny HP; Hartmann K; Sotlar K; Damaj G; Hermine O; Verstovsek S; Metcalfe DD; Gotlib J; Akin C; Valent P Haematologica; 2016 Oct; 101(10):1133-1143. PubMed ID: 27694501 [TBL] [Abstract][Full Text] [Related]
45. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL. Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351 [TBL] [Abstract][Full Text] [Related]
46. Mastocytosis: a rare case of anaphylaxis in paediatric age and literature review. Silva I; Carvalho S; Pinto PL; Machado S; Rosado Pinto J Allergol Immunopathol (Madr); 2008; 36(3):154-63. PubMed ID: 18680704 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of the WHO criteria for the classification of patients with mastocytosis. Sánchez-Muñoz L; Alvarez-Twose I; García-Montero AC; Teodosio C; Jara-Acevedo M; Pedreira CE; Matito A; Morgado JM; Sánchez ML; Mollejo M; Gonzalez-de-Olano D; Orfao A; Escribano L Mod Pathol; 2011 Sep; 24(9):1157-68. PubMed ID: 21552214 [TBL] [Abstract][Full Text] [Related]
48. Diagnostic criteria and classification of mastocytosis in 2014. Akin C; Valent P Immunol Allergy Clin North Am; 2014 May; 34(2):207-18. PubMed ID: 24745670 [TBL] [Abstract][Full Text] [Related]
49. De novo mast cell leukemia without CD25 expression and KIT mutations: a rare case report in a 13-year-old child. Zheng Y; Nong L; Liang L; Wang W; Li T Diagn Pathol; 2018 Feb; 13(1):14. PubMed ID: 29458385 [TBL] [Abstract][Full Text] [Related]
50. Strategies in childhood and adult mastocytosis. Kissling S; Kernland K; Gerbig AW; Hunziker T Dermatology; 1999; 198(4):426-30. PubMed ID: 10490305 [No Abstract] [Full Text] [Related]
51. A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase. Bibi S; Zhang Y; Hugonin C; Mangean MD; He L; Wedeh G; Launay JM; Van Rijn S; Würdinger T; Louache F; Arock M Oncotarget; 2016 Dec; 7(50):82985-83000. PubMed ID: 27783996 [TBL] [Abstract][Full Text] [Related]
52. Classification and response criteria in mast cell disorders: time to revise? Valent P; Horny HP Int Arch Allergy Immunol; 2011; 155(3):306-8. PubMed ID: 21293151 [No Abstract] [Full Text] [Related]
53. Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis. Pardanani A; Chen D; Abdelrahman RA; Reichard KK; Zblewski D; Wood AJ; McClure RF; Butterfield JH; Hanson CA; Tefferi A Leukemia; 2013 Oct; 27(10):2091-4. PubMed ID: 23896642 [No Abstract] [Full Text] [Related]
54. Southwestern Internal Medicine Conference: mastocytosis: developments during the past decade. Gruchalla RS Am J Med Sci; 1995 Jun; 309(6):328-38. PubMed ID: 7771504 [TBL] [Abstract][Full Text] [Related]